A Safety and Efficacy Study of Sufentanil Transdermal System in Patients With Chronic Pain Due to Cancer
Phase 2
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2009-07-22
- Last Posted Date
- 2015-09-15
- Lead Sponsor
- Labtec GmbH
- Registration Number
- NCT00943566
© Copyright 2024. All Rights Reserved by MedPath